Price
$0.72
Decreased by -0.62%
Dollar volume (20D)
289.66 K
ADR%
7.00
Shares float
4.30 M
Shares short
1.12 M [25.96%]
Shares outstanding
4.80 M
Market cap
3.64 M
Beta
1.34
Price/earnings
N/A
20D range
0.60 0.77
50D range
0.60 1.05
200D range
0.60 4.32

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease.

It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 12, 25 -0.47
Increased by +89.76%
-0.81
Increased by +41.98%
Mar 25, 25 -0.69
Increased by +89.30%
-1.99
Increased by +65.27%
Nov 7, 24 -2.32
Decreased by -428.18%
-3.35
Increased by +30.63%
Aug 9, 24 -3.32
Decreased by -526.42%
-2.93
Decreased by -13.31%
May 13, 24 -4.59
Decreased by -750.00%
-4.80
Increased by +4.38%
Mar 26, 24 -6.45
Decreased by -199.69%
-5.17
Decreased by -24.76%
Nov 9, 23 -0.44
Increased by +89.00%
-0.39
Decreased by -12.82%
Aug 11, 23 -0.53
Increased by +91.17%
-0.45
Decreased by -17.78%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-2.23 M
Increased by +36.77%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Increased by +100.00%
-3.34 M
Decreased by -12.55%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-3.49 M
Increased by +3.03%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-4.08 M
Decreased by -20.25%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by -100.00%
-3.53 M
Decreased by -50.73%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 -250.00 K
Decreased by N/A%
-2.97 M
Increased by +20.13%
Increased by +1.19 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-3.60 M
Increased by +9.90%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-3.39 M
Decreased by -44.75%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY